Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Progyny, Inc. Announces Second Quarter 2025 Results
04:02pm, Thursday, 07'th Aug 2025
Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance
Progyny (PGNY) Earnings Expected to Grow: Should You Buy?
11:08am, Thursday, 31'st Jul 2025
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Progyny Study Reveals Gap Between Perceptions and Realities in Women's Health Benefits Coverage
09:19am, Wednesday, 30'th Jul 2025
Increased awareness of expanded women's health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings Increased awareness of expande
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Thursday, 24'th Jul 2025
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced a new partnership with ŌURA , maker of the w
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength?
08:36am, Wednesday, 09'th Jul 2025
Progyny (PGNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report
08:09am, Tuesday, 08'th Jul 2025
Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health
09:10am, Tuesday, 24'th Jun 2025
With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering With nearly one third of women impacted by p
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution
09:02am, Tuesday, 10'th Jun 2025
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits. The collaboration will enable Amazon
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
09:03am, Thursday, 29'th May 2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the addition of healthcare veteran Elizabeth B
Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board
09:05am, Wednesday, 14'th May 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the appointment of Morehouse School of Medicin
Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference
03:58pm, Monday, 12'th May 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Progyny's Chief Executive Officer, Pete A
Progyny, Inc. (PGNY) Q1 2025 Earnings Call Transcript
08:05pm, Thursday, 08'th May 2025
Progyny, Inc. (NASDAQ:PGNY ) Q1 2025 Results Conference Call May 8, 2025 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Pete Anevski - Chief Executive Officer Michae
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates
07:55pm, Thursday, 08'th May 2025
Progyny (PGNY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.39 per share a year ago.
Progyny, Inc. Announces First Quarter 2025 Results
04:14pm, Thursday, 08'th May 2025
Reports Record Revenue of $324.0 Million, Reflecting 16.5% GrowthRaises Full Year Guidance Due to Strong Start to the YearEarly Selling Season Activity Reflects Ongoing Demand in Women's Health and Fa
